Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

Blood Samples

Forecast
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Department of Commerce is seeking to procure healthy GMP-grade Leukopaks and fresh healthy whole blood samples. These biological materials will be utilized for forensic DNA testing, the production of standard reference materials, the execution of inter-laboratory studies, and the publication of allele frequencies. This requirement is listed as a forecast with the place of performance located in Gaithersburg. The procurement falls under NAICS code 621991, and interested parties may coordinate with the designated point of contact, Daniel Dender, or the Office of Small and Disadvantaged Business Utilization.

General Info

Department of Commerce seeks GMP-grade Leukopaks and whole blood samples for forensic DNA testing.

Agency

Department of Commerce

NAICS

621991 - Blood and Organ Banks

Place of Performance

GAITHERSBURG, MD, USA

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Get what you need to respond

No documents were posted with this contract.

  • Buyer contactEmail
  • Original solicitationLink to the source posting
Get the buyer contact

Ask CLEATUS

I've read this contract. Ask me anything.

Timeline

PhaseForecast
Posted

forecast

Prepare for this forecast

Research the agency, track this forecast, and prepare your capture plan before the solicitation opens.

Organization & Contact Information

Show more
AgencyDepartment of Commerce
Contacts2 people available
OfficeN/A
Organization / Agency
Department of Commerce
Office AddressN/A

Full Description

Show more
Procure Healthy GMP-grade Leukopaks and Fresh Healthy Whole Blood samples for forensic DNA testing, SRM production, inter-laboratory studies, and publication of allele frequencies.

Similar Contracts

Same NAICS industry code

NAICS: 621991
Grant
Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
Solicitation # RFA-CA-28-004
The National Cancer Institute (NCI) has issued a Notice of Funding Opportunity (RFA-CA-28-004) for a limited competition to support the continuation of two critical biospecimen banking resources: the National Clinical Trials Network (NCTN) Biobanks and the Early-Phase and Experimental Clinical Trials (EET) Biobank. The primary objective is to maintain national resources for the collection, processing, storage, and distribution of clinically annotated human biospecimens to enable translational cancer research, biomarker development, and the investigation of drug response and resistance mechanisms. The NCI intends to fund approximately six awards with a total program funding of $19 million for fiscal year 2027, with a maximum direct cost limit of $3.0 million per year and a requested project period of six years. Applications are evaluated based on scientific and technical merit through the NIH peer-review system, focusing on significance, environment, and the likelihood of the project to exert a sustained influence on the research field. Eligible organizations must maintain active SAM and eRA Commons registrations and provide specific documentation, including the current scale of operation, accomplishments, and standard operating procedures. Awardees are required to implement robust quality assurance programs, adhere to Federal Human Subjects Regulations under 45 CFR 46, and follow strict cybersecurity incident reporting protocols, including notifying the HHS within 48 hours of discovery. There is no set-aside status specified for this opportunity.
National Institutes Of Health

POSTED

about 1 month ago

DEADLINE

in 3 months
View Details
NAICS: 621991
Grant
Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
Solicitation # RFA-CA-28-004
The National Cancer Institute is issuing a limited competition Notice of Funding Opportunity, solicitation RFA-CA-28-004, to support the continuation of two critical biospecimen banking resources. These resources include the National Clinical Trials Network Biobanks, which support the NCTN and the Community Oncology Research Program, and the Early-Phase and Experimental Clinical Trials Biospecimen Bank, which supports the ETCTN and other early-phase experimental trials. The primary objective is to maintain national infrastructure for the collection, processing, storage, and distribution of high-quality, clinically annotated human biospecimens to enable translational cancer research, biomarker development, and the study of drug response and resistance. Eligible organizations must submit applications by February 12, 2027, to be considered for funding. All submissions will undergo a standard NIH peer-review process, and only meritorious applications will be selected. These banks are essential for linking biospecimens to clinical outcome data from large multi-site trials and supporting the development of novel cancer therapies through pharmacokinetic and pharmacodynamic analyses.
National Cancer Institute

POSTED

about 1 month ago

DEADLINE

in 3 months
View Details
NAICS: 621991
SLED
Mobile Health Unit OperationsThe contract titled Mobile Health Unit Operations seeks a subcontractor to manage the operation and maintenance of mobile units tasked with delivering vision, dental, and hearing services to underserved communities across the region. These mobile units will serve as critical access points for essential health care, ensuring that populations with limited transportation or geographic barriers receive timely and consistent medical attention. The work involves the full lifecycle management of the units, including routine maintenance, repairs, staffing coordination, logistics, and compliance with health and safety standards to guarantee reliable service delivery. The contract is categorized as a subcontract under NAICS code 621991 and is solicited by the Houston-Galveston Area Council through the Texas SmartBuy platform. The solicitation was posted on July 22, 2026, with a response deadline of July 29, 2027, providing over a year for prospective vendors to prepare proposals. The place of performance spans the region served by the council, though exact locations are not specified, indicating flexibility in service deployment based on community need. While details on set-aside status and point of contact are unavailable, the focus remains on operational excellence and equitable access to preventive and diagnostic health services in areas lacking permanent clinical infrastructure.
HOUSTON-GALVESTON AREA COUNCIL

POSTED

4 months ago

DEADLINE

in 8 months
View Details

Earlier notices in this NAICS code

Posted before this notice, open and closed

Research this forecast and prepare for the solicitation

Every solicitation package arrives shredded into a compliance breakdown and matched to your past performance, with incumbent history and alerts on amendments and award.

Miguel
Hillary
Keith Deutsch
Christine

Join 900+ contractors already using CLEATUS